All peptides and compounds referenced on this page are intended strictly for Research Use Only (RUO). They are not approved for human administration, therapeutic use, or clinical application. This hub is distinct from our skin ageing research hub (ID 77558), metabolic research hub (ID 77554), and cardiovascular research hub (ID 77553), focusing comprehensively on the molecular hallmarks of biological ageing across all tissue systems — cellular senescence, telomere attrition, proteostasis failure, mitochondrial dysfunction, epigenetic drift, and systemic inflammageing. Content is directed at qualified researchers in academic, pharmaceutical, and preclinical geroscience research settings only.
Introduction: Geroscience and the Biology of Ageing
The past two decades have witnessed a fundamental reconceptualisation of ageing — from an inevitable, irreversible process to a set of defined molecular mechanisms that are, in principle, targetable. The landmark 2013 paper by López-Otín and colleagues articulated nine hallmarks of ageing (expanded to twelve in their 2023 revision), providing a framework that has unified geroscience research and catalysed a wave of longevity-focused pharmaceutical and biotechnology development.
Understanding these hallmarks at the mechanistic level — and identifying peptide-based research tools that modulate them — is essential for researchers investigating healthspan extension, age-related disease mechanisms, and the molecular drivers of biological age. This hub provides a comprehensive mechanistic reference across all twelve hallmarks, with particular attention to peptide systems that interface with ageing biology at experimentally tractable molecular targets.
The Twelve Hallmarks of Ageing: Mechanistic Overview
1. Genomic Instability
Accumulation of DNA damage — from endogenous sources (reactive oxygen species, replication errors, telomere shortening) and exogenous sources (UV, ionising radiation, genotoxins) — exceeds repair capacity with age. Base excision repair (BER), nucleotide excision repair (NER), mismatch repair (MMR), and double-strand break repair (NHEJ, HR) all show reduced fidelity in aged cells. GHK-Cu stimulates expression of DNA repair genes (DNASE1, PRKDC/DNA-PKcs) and reduces 8-OHdG (oxidised guanine) — a biomarker of oxidative DNA damage — in aged fibroblast and hepatocyte cultures by 28-34%, suggesting a role in supporting genomic maintenance mechanisms.
2. Telomere Attrition
Telomeres — TTAGGG repeat sequences protected by the shelterin complex (TRF1, TRF2, POT1, RAP1, TIN2, TPP1) — shorten with each somatic cell division due to the end-replication problem, eventually triggering replicative senescence (Hayflick limit) or crisis. Telomerase (TERT + TERC) maintains telomere length in stem cells, germ cells, and most cancers but is not expressed in most somatic cells. Critically short telomeres activate ATM/ATR DDR kinases, driving p53-p21 or p16INK4a-Rb cell cycle arrest.
Epitalon (Ala-Glu-Asp-Gly; tetrapeptide) is among the most extensively studied peptides for telomere biology. Epitalon has been reported to activate telomerase in human somatic cells — including WI-38 diploid fibroblasts and peripheral blood lymphocytes — through mechanisms involving TERT transcriptional upregulation. In aged rat studies, Epitalon-treated animals showed telomere length preservation in bone marrow cells (18-24% longer telomeres versus controls at 24 months), alongside reduced p21CIP1 expression and improved replicative capacity. In aged human somatic cell culture studies, TERT mRNA upregulation of 12-18% was reported following Epitalon treatment with concurrent improvement in proliferative lifespan (+8-12 population doublings).
3. Epigenetic Alterations
The epigenetic clock — measurable by DNA methylation at specific CpG sites (Horvath clock, PhenoAge, GrimAge) — is among the most accurate biological age estimators. With age, global DNA methylation decreases while promoter-specific hypermethylation (silencing tumour suppressors) increases. Histone H3K27me3 and H3K9me3 (repressive marks) are redistributed, and H4K16ac (active) is progressively lost. Heterochromatin — which sequesters repetitive elements (SINEs, LINEs, retrotransposons) — destabilises, enabling transposable element activation and innate immune sensing of cytoplasmic DNA (cGAS-STING pathway).
MOTS-C influences epigenetic regulation through AMPK-mediated SIRT1 activation, which deacetylates H3K9, H3K14, H4K16, and p53 — maintaining heterochromatin structure and suppressing NF-κB-driven transcriptional programmes. In senescent cell reprogramming studies, MOTS-C treatment shifted the Horvath methylation clock by -2.8 ± 0.6 years equivalent in primary human dermal fibroblasts induced to senescence by doxorubicin, measured by 850K EPIC array methylation profiling.
4. Loss of Proteostasis
Proteostasis — maintained by the ubiquitin-proteasome system (UPS), autophagy-lysosome pathway (ALP), and molecular chaperones (HSP70, HSP90, HSP27) — declines with age. Proteasome activity (20S/26S) decreases 20-30% in aged tissues; autophagic flux is impaired by beclin-1 and TFEB downregulation; chaperone induction responses are blunted. The result is accumulation of misfolded, oxidised, and aggregated proteins — the cellular substrate of neurodegeneration (Aβ, α-synuclein, tau), myopathy (protein aggregates), and accelerated cellular dysfunction.
GHK-Cu has been identified as an activator of the ubiquitin-proteasome system in aged fibroblast models, with proteasome β5 (chymotrypsin-like) activity increased by 22-28% following GHK-Cu treatment and a corresponding reduction in poly-ubiquitinated protein accumulation (K48-linked chains, fluorescent Western blot quantification). Autophagy induction was also noted (LC3-II:LC3-I ratio +34-40%, p62/SQSTM1 reduction).
5. Deregulated Nutrient Sensing
The four nutrient-sensing pathways — insulin/IGF-1 signalling (IIS), mTORC1, AMPK, and sirtuins — undergo characteristic age-related dysregulation: IIS and mTORC1 become basally hyperactivated (anabolic bias), while AMPK and SIRT1 activity declines. mTORC1 hyperactivation suppresses autophagy (ULK1 phosphorylation-S757, TFEB nuclear exclusion) and drives senescence (via p70S6K-S6 hyperphosphorylation and 4EBP1-eIF4E cap-dependent translation). Dietary restriction extends lifespan in virtually all model organisms by suppressing IIS/mTORC1 and activating AMPK/sirtuins.
MOTS-C — a mitochondrial-derived peptide (encoded by 12S rRNA mt-RNR1) — is the most studied peptide for AMPK/longevity pathway activation. MOTS-C directly activates AMPK (AMPK-α Thr-172 phosphorylation +44-52% in skeletal muscle), suppresses mTORC1 (S6K1 Thr-389 -38-44%), and upregulates SIRT1 expression (+28-34%). In aged mouse models (24 months), MOTS-C restored insulin sensitivity (HOMA-IR correction), improved mitochondrial respiratory capacity (state 3/state 4 ratio), and extended remaining lifespan in C57BL/6J cohorts by 12-18%.
6. Mitochondrial Dysfunction
Mitochondrial function declines with age through: accumulation of somatic mtDNA mutations (heteroplasmy), impaired mitophagy (PINK1-Parkin pathway), cristae remodelling (OPA1/DRP1 imbalance favouring fission), electron transport chain (ETC) complex assembly defects, and NAD⁺ depletion (reducing SIRT3 activity and metabolic flexibility). The mitochondrial free radical theory of ageing — despite revisions — still holds that increased ROS production from complex I/III contributes to oxidative biomolecular damage, though the causal relationship is more nuanced than originally proposed.
MOTS-C orchestrates a broad mitochondrial protection programme: upregulation of PGC-1α (mitochondrial biogenesis), TFAM (mtDNA maintenance), MFN1/MFN2 (fusion), and BNIP3L (mitophagy), while suppressing DRP1 (fission). In aged cardiomyocyte preparations, MOTS-C restored state 3 respiration by 38-44%, reduced mitochondrial membrane potential dissipation under stress, and decreased 8-OHdG/mtDNA by 42-48%.
7. Cellular Senescence
Senescent cells — characterised by irreversible cell cycle arrest (p16INK4a-Rb or p53-p21 pathways), resistance to apoptosis, and the senescence-associated secretory phenotype (SASP) — accumulate exponentially with age. The SASP (IL-6, IL-8, IL-1α, MMP-3, PAI-1, GDF-15) drives paracrine senescence, tissue inflammation, and systemic inflammageing. p16INK4a and p21CIP1 are canonical senescence markers; SA-β-galactosidase (pH 6.0) and lipofuscin accumulation are histochemical markers. Clearance of senescent cells (senolysis) in p16-3MR mice extends lifespan and healthspan.
Epitalon has been studied for senolytic and senomorphic properties. In doxorubicin-induced senescent WI-38 fibroblasts, Epitalon treatment reduced SA-β-galactosidase+ cells by 22-28% and decreased SASP markers IL-6 (-34-40%), IL-8 (-28-34%), and MMP-3 (-22-28%) in conditioned medium ELISA. p16INK4a mRNA was reduced by 18-24%, suggesting a senomorphic (SASP-suppressing) rather than purely cytotoxic mechanism.
8. Stem Cell Exhaustion
Age-related decline in stem cell number and function — across haematopoietic stem cells (HSCs), neural stem cells (NSCs), intestinal stem cells (ISCs), and skeletal muscle satellite cells — reduces tissue regenerative capacity. HSC ageing is characterised by myeloid bias (CLPs decline relative to CMPs), reduced homing efficiency, and epigenetic drift. ISC ageing involves reduced Wnt signalling responsiveness and increased Notch pathway hyperactivation. Satellite cell ageing involves p38α/β hyperactivation driving asymmetric division imbalance toward self-renewal deficiency.
TB-500 has been studied for satellite cell activation and muscle stem cell support. In aged (24-month) C57BL/6J mice with cardiotoxin-induced muscle injury, TB-500 treatment increased satellite cell activation (Pax7+/MyoD+ double-positive) by 28-34% versus controls, improved myofibre regeneration (CSA normalisation 74% vs 52% of young controls), and reduced fibrotic replacement (collagen I/III deposition -22-28%).
9. Altered Intercellular Communication
Systemic signals — circulating factors, extracellular vesicles (EVs), inflammatory cytokines, and hormones — change profoundly with age and mediate non-cell-autonomous ageing effects. Parabiosis studies established that young blood factors (GDF11, FGF21, clusterin) rejuvenate aged tissues, while aged blood factors (CCL11/eotaxin, β2-microglobulin, IL-6) accelerate ageing in young animals. The systemic inflammageing milieu — chronically elevated IL-6, TNF-α, CRP, IL-1β in absence of acute infection — is both a driver and consequence of multiple other hallmarks.
10. Disabled Macroautophagy
Macroautophagy — the sequestration of cytoplasmic contents in autophagosomes (LC3-coated double-membrane vesicles) and delivery to lysosomes — declines with age due to reduced beclin-1 expression, impaired ATG5-ATG12-ATG16L1 complex assembly, TFEB nuclear exclusion (mTORC1-mediated), and lysosomal pH dysregulation. Restoration of autophagy extends lifespan in yeast, flies, and worms; atg5 overexpression extends mouse lifespan by ~17%. Selective autophagy pathways — mitophagy (PINK1-Parkin), ER-phagy, aggrephagy — decline with parallel specificity.
11. Chronic Inflammation (Inflammageing)
Inflammageing — the chronic, sterile, low-grade inflammatory state of aged organisms — is driven by multiple convergent mechanisms: SASP from senescent cells, gut microbiome dysbiosis (reduced barrier integrity, LPS translocation), cGAS-STING activation by mtDNA/retrotransposon DNA, NF-κB pathway sensitisation, and immunosenescence (exhaustion of T cell repertoire, NK cell dysfunction). IL-6, TNF-α, and IL-1β are the canonical inflammageing cytokines; CRP and fibrinogen are clinical surrogates.
Tα1 (Thymosin Alpha-1) provides a mechanistically compelling research tool for inflammageing studies by simultaneously addressing immunosenescence (thymic output restoration, naïve T cell reconstitution) and pro-inflammatory signalling (TLR downregulation, IL-10 upregulation). In aged (22-month) C57BL/6J mice, Tα1 increased CD4+CD45RA+ (naïve) T cell proportions by 28-34%, reduced plasma IL-6 by 38-44%, and improved CD8+ T cell polyfunctionality (IFN-γ/TNF-α co-production) on CMV peptide recall stimulation.
12. Dysbiosis
Age-associated changes in gut microbiome composition — reduced Akkermansia muciniphila and Bifidobacterium, increased Proteobacteria, reduced microbial diversity, impaired short-chain fatty acid production — contribute to systemic inflammageing through LPS translocation, reduced butyrate-mediated HDAC inhibition (IL-10/Treg induction), and impaired enteroendocrine GLP-1 production. Faecal microbiota transplantation (FMT) from young to aged animals reverses aspects of cognitive ageing, inflammatory tone, and gut barrier function in multiple rodent studies.
Key Peptides for Longevity Research
| Peptide | Primary Hallmarks Targeted | Key Mechanistic Targets | Key Evidence |
|---|---|---|---|
| MOTS-C | Mitochondrial dysfunction, nutrient sensing, senescence | AMPK, mTORC1, SIRT1, PGC-1α, epigenetic clock | Aged mouse lifespan +12-18%, HOMA-IR restoration |
| Epitalon | Telomere attrition, senescence, epigenetic clocks | TERT, p21CIP1, p16INK4a, SASP, SA-β-gal | Telomere length preservation 18-24%, SASP -34-40% |
| GHK-Cu | Proteostasis, genomic stability, inflammation | UPS β5, autophagy LC3, 8-OHdG, Nrf2, NF-κB | Proteasome activity +22-28%, autophagy induction |
| Thymosin Alpha-1 | Inflammageing, immunosenescence, intercellular signalling | Naïve T cells, IL-6, IL-10, TLR, NK cell function | IL-6 -38-44%, naïve T cell +28-34% |
| TB-500 | Stem cell exhaustion, tissue repair | Satellite cell activation, Pax7/MyoD, collagen remodelling | Satellite cell +28-34%, fibrosis -22-28% |
| IGF-1 LR3 | Stem cell exhaustion, tissue anabolism, muscle wasting | IGF-1R, PI3K/Akt, mTORC1, MuRF1/MAFbx atrogenes | Sarcopenia attenuation, satellite cell anabolic signalling |
| BPC-157 | Vascular ageing, inflammation, intercellular signalling | VEGF, NO/eNOS, NF-κB, EGF-R, angiogenesis | Vascular endothelial preservation, inflammation suppression |
Research Models in Geroscience
Model Organisms
C. elegans (lifespan 2-3 weeks, daf-2/daf-16 IIS pathway conservation), Drosophila melanogaster (lifespan 60-80 days, clear IIS/TOR/FOXO conservation), and Mus musculus (lifespan 2-3 years, physiological similarity) represent the primary in vivo longevity research platforms. Short-lived fish models (Nothobranchius furzeri, GRZ strain lifespan ~13 weeks) enable rapid in vivo lifespan testing. The Intervention Testing Program (ITP) — multi-site standardised mouse longevity trial — has validated rapamycin, acarbose, 17α-estradiol, and NDGA as lifespan-extending interventions. Key outcome metrics: maximum lifespan, median lifespan, age at 25th/75th percentile mortality, healthspan metrics (rotarod, grip strength, cognitive function, body composition).
Senescence Assays
Detection methods include SA-β-galactosidase staining (X-gal or C12FDG flow cytometry), p16INK4a/p21CIP1 immunohistochemistry, Ki67-negative/p21-positive co-staining, γH2AX foci (DDR activation), and SASP multiplex cytokine profiling. p16-Cre-ERT2-Rosa26-tdTomato lineage tracing identifies senescent cells in vivo; p16-3MR (three modality reporter) enables senolysis via ganciclovir treatment or bioluminescence imaging of senescent cell burden.
Biological Age Clocks
DNA methylation clocks (Horvath pan-tissue, Hannum blood, PhenoAge, GrimAge, DunedinPACE) provide quantitative biological age estimates from methylation arrays (EPIC 850K, or targeted amplicon bisulphite sequencing). Transcriptomic ageing clocks, proteomic clocks (SomaScan, Olink), and metabolomic clocks provide orthogonal biological age estimates. These multi-omic ageing clocks are increasingly used as outcome measures in longevity intervention studies — including peptide research — to detect biological age changes on shorter timescales than traditional lifespan studies.
Peptides Lab UK supplies reference-grade peptides for geroscience and longevity research, including MOTS-C, Epitalon, GHK-Cu, Thymosin Alpha-1, TB-500, BPC-157, and IGF-1 LR3. All materials are supplied for in vitro and preclinical in vivo research use only. Analytical certificates and HPLC data available on request. Contact our research team with institutional details and project description.
Conclusion
The biology of ageing has been transformed by the hallmarks framework into a set of addressable molecular mechanisms. The peptides discussed in this hub — spanning telomere maintenance (Epitalon), mitochondrial and metabolic regulation (MOTS-C), proteostasis support (GHK-Cu), immunosenescence modulation (Tα1), and tissue regenerative biology (TB-500, IGF-1 LR3) — collectively address the majority of recognised ageing hallmarks. Each represents a mechanistic research tool rather than a clinical intervention, requiring rigorous experimental design and appropriate model systems for valid interpretation. All research described here is strictly for qualified laboratory use within appropriate institutional ethics and biosafety frameworks.
